高林股 (1531.TW) 2025Q2 shows an explosive surge in contract liabilities growth (over 30%). The company’s future revenue outlook is strongly boosted by a sharp increase in orders, but investors should be cautious of concentration risk, delivery progress, and whether management can handle intensified operational demands. Ongoing monitoring of fulfillment and revenue conversion is recommended.